|
87
|
304
|
6xbhA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor uaw247 |
|
92
|
306
|
6xb0A |
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design |
|
94
|
313
|
6xa9A |
Sars cov-2 plpro in complex with isg15 c-terminal domain propargylamide |
|
88
|
304
|
6xa4A |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with uaw241 |
|
87
|
309
|
6xaaA |
Sars cov-2 plpro in complex with ubiquitin propargylamide |
|
88
|
306
|
6xb1A |
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design |
|
89
|
348
|
6x4iA |
Crystal structure of nsp15 endoribonuclease from sars cov-2 in the complex with 3'-uridinemonophosphate |
|
88
|
348
|
6wxcA |
Crystal structure of nsp15 endoribonuclease from sars cov-2 in the complex with potential repurposing drug tipiracil |
|
95
|
320
|
6wx4D |
Crystal structure of the sars cov-2 papain-like protease in complex with peptide inhibitor vir251 |
|
95
|
315
|
6wzuA |
The crystal structure of papain-like protease of sars cov-2 , p3221 space group |
|
85
|
348
|
6x1bA |
Crystal structure of nsp15 endoribonuclease from sars cov-2 in the complex with the product nucleotide gpu. |
|
23
|
113
|
6wxdA |
Sars-cov-2 nsp9 rna-replicase |
|
33
|
123
|
6wvnB |
Crystal structure of nsp16-nsp10 from sars-cov-2 in complex with 7-methyl-gpppa and s-adenosylmethionine. |
|
92
|
318
|
6wuuA |
Crystal structure of the sars cov-2 papain-like protease in complex with peptide inhibitor vir250 |
|
101
|
299
|
6wvnA |
Crystal structure of nsp16-nsp10 from sars-cov-2 in complex with 7-methyl-gpppa and s-adenosylmethionine. |
|
30
|
116
|
6wtcB |
Crystal structure of the second form of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2 |
|
82
|
306
|
6wtkA |
Feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication |
|
28
|
73
|
6wtcA |
Crystal structure of the second form of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2 |
|
85
|
306
|
6wtjA |
Feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication |
|
85
|
302
|
6wttA |
Crystals structure of the sars-cov-2 (covid-19) main protease with inhibitor gc-376 |
|
87
|
306
|
6wtmA |
Feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication |
|
100
|
299
|
6wrzA |
Crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 with 7-methyl-gpppa and s-adenosyl-l-homocysteine in the active site and sulfates in the mrna binding groove. |
|
32
|
121
|
6wrzB |
Crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 with 7-methyl-gpppa and s-adenosyl-l-homocysteine in the active site and sulfates in the mrna binding groove. |
|
96
|
316
|
6wrhA |
The crystal structure of papain-like protease of sars cov-2 , c111s mutant |
|
28
|
122
|
6wq3B |
Crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 in complex with 7-methyl-gpppa and s-adenosyl-l-homocysteine. |
|
84
|
306
|
6wqfA |
Structural plasticity of the sars-cov-2 3cl mpro active site cavity revealed by room temperature x-ray crystallography |
|
30
|
121
|
6wqdB |
The 1.95 a crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars-cov-2 |
|
64
|
169
|
6wojA |
Structure of the sars-cov-2 macrodomain (nsp3) in complex with adp-ribose |
|
96
|
299
|
6wq3A |
Crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 in complex with 7-methyl-gpppa and s-adenosyl-l-homocysteine. |
|
30
|
74
|
6wqdA |
The 1.95 a crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars-cov-2 |
|
87
|
306
|
6wnpA |
X-ray structure of sars-cov-2 main protease bound to boceprevir at 1.45 a |
|
22
|
114
|
6wksBBB |
Structure of sars-cov-2 nsp16/nsp10 ternary complex |
|
90
|
298
|
6wksAAA |
Structure of sars-cov-2 nsp16/nsp10 ternary complex |
|
69
|
403
|
6s8cA |
Post-fusion conformation of the envelope protein of tick-borne encephalitis virus with longer stem |
|
37
|
191
|
6p6zA |
Hcv ns3/4a protease domain of genotype 4a with an extended linker in complex with glecaprevir |
|
52
|
200
|
6p6lA |
Hcv ns3/4a protease domain of genotype 1a in complex with glecaprevir |
|
49
|
193
|
6p6vA |
Hcv ns3/4a protease domain of genotype 5a in complex with glecaprevir |
|
40
|
197
|
6p6qA |
Hcv ns3/4a protease domain of genotype 1a3a chimera in complex with grazoprevir |
|
53
|
202
|
6p6oA |
Hcv ns3/4a protease domain of genotype 1a d168e in complex with glecaprevir |
|
34
|
189
|
6p6tA |
Hcv ns3/4a protease domain of genotype 4a in complex with glecaprevir |
|
48
|
201
|
6p6mA |
Hcv ns3/4a protease domain of genotype 1a c159 in complex with glecaprevir |
|
52
|
201
|
6p6rA |
Hcv ns3/4a protease domain of genotype 1a3a chimera in complex with glecaprevir |
|
29
|
115
|
6m5iB |
Crystal structure of 2019-ncov nsp7-nsp8c complex |
|
24
|
81
|
6m5iA |
Crystal structure of 2019-ncov nsp7-nsp8c complex |
|
90
|
306
|
6lnqA |
The co-crystal structure of sars-cov 3c like protease with aldehyde inhibitor m7 |
|
613
|
1948
|
5dcaA |
Crystal structure of yeast full length brr2 in complex with prp8 jab1 domain |
|
554
|
1721
|
5urjA |
Crystal structure of human brr2 in complex with t-3905516 |
|
577
|
1722
|
5urmA |
Crystal structure of human brr2 in complex with t-1206548 |
|
1
|
44
|
1cwxA |
Solution structure of the hepatitis c virus n-terminal capsid protein 2-45 [c-hcv(2-45)] |
|
21
|
165
|
1bt7A |
The solution nmr structure of the n-terminal protease domain of the hepatitis c virus (hcv) ns3-protein, from bk strain, 20 structures |
